Sean Matthew McBride MD MPH
Head & Neck, Urologic Cancer
Chief, Manhattan Service, Department of Radiation Oncology Associate Attending, Memorial Sloan Kettering Cancer Center
530 East 74th StreetNew York, NY 10021
Overview of Dr. McBride
Dr. Sean McBride is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Memorial Hospital for Cancer and allied Diseases, and Shore Medical Center. He received his medical degree from Yale School of Medicine and has been in practice 18 years. He is one of 133 doctors at Memorial Sloan Kettering Cancer Center and one of 24 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2009 - 2013
Harvard T.H. Chan School of Public HealthMPH, 2011 - 2012
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 2008 - 2009
Yale School of MedicineClass of 2008
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2013 - 2028
NJ State Medical License 2015 - 2027
MA State Medical License 2011 - 2014
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Clinical Trials
- Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer Start of enrollment: 2020 Mar 03
Roles: Contact
Publications & Presentations
PubMed
- Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience.Sian Cooper, Victoria Sarah Brennan, Filippo Alongi, Joan Chick, Daniel Gorovets
Clinical and Translational Radiation Oncology. 2027-01-01 - Health services research and advocacy in US cancer care: pathways from evidence to implementation.Nipun Gorantla, Manju George, Nishwant Swami, Milit S Patel, James Fan Wu
Lancet Regional Health. Americas. 2026-11-01 - Radiation Oncology at a Crossroads: Interpreting the Evidence on Proton Versus Photon Radiotherapy for Oropharyngeal Cancer.Sudarshan Ramanan, George Ashji, Khoi Nguyen, Danil Ratnikov, Eric J Sherman
Journal of Clinical Oncology. 2026-10-14
Lectures
- Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma...2019 ASCO Annual Meeting - 6/1/2019
- Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients.2019 ASCO Annual Meeting - 6/1/2019
- Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa).2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
Court Decision Favoring California Telehealth Restrictions AppealedSeptember 9th, 2025- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline (2026)August 15th, 2025
- SBRT Well Tolerated After Radical ProstatectomyMay 15th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: